ADMA Biologics, Inc. Reports First Quarter 2014 Financial And Operational Results
5/13/2014 7:08:41 AM
ADMA Biologics, Inc. (OTCQB:ADMA), a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today reported its financial and operational results for the first quarter of 2014 and announced recent company developments and anticipated milestones for 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by